Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ vs Valsartan in Hypertension
NCT00250562Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, hydrochlorothiazide in essential hypertension, sponsored by Novartis. Started Oct 2005; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00250562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250562.